CN Stock MarketDetailed Quotes

603439 Guizhou Sanli Pharmaceutical Co.,Ltd.

Watchlist

12.90
-0.51-3.80%

Market Closed Jan 7 15:00 CST

5.29BMarket Cap16.06P/E (TTM)

Guizhou Sanli Pharmaceutical Co.,Ltd. Key Stats

Earnings

Revenue Breakdown

Financial Indicators

Income Statement

Balance Sheet

Cash Flow

Guizhou Sanli Pharmaceutical Co.,Ltd. Earnings Estimates

Revenue

EPS

EBIT

Revenue is based on 2 analyst forecasts. Estimate data is from S&P, and actual data is from Income Statement

Currency: CNY

Actual

Estimate

Date	Period	Revenue/Estimate	Earnings Call
--	2025/FY	-- / 3.035B	--
--	2024/FY	-- / 2.463B	--
--	2023/FY	1.635B / 1.560B	--
--	2022/FY	1.201B / 1.204B	--

DatePeriodRevenue/EstimateEarnings Call

--2025/FY-- / 3.035B--

--2024/FY-- / 2.463B--

--2023/FY1.635B / 1.560B--

--2022/FY1.201B / 1.204B--

--------

Unlock Free Earnings Estimates

Open Account

Guizhou Sanli Pharmaceutical Co.,Ltd. Earnings Reports

Guizhou Sanli: Report of Guizhou Sanli Pharmaceutical Co., Ltd. for the third quarter of 2024

Oct 28, 2024 12:00 ET

Report for the third quarter of 2024 of Guizhou Sanli Pharmaceutical Co., Ltd.

Oct 28, 2024 12:00 ET

Guizhou Sanli Pharmaceutical Co., Ltd. 2024 Semi-Annual Report

Aug 28, 2024 12:00 ET

2024 Semi-Annual Report Summary

Aug 28, 2024 12:00 ET

Analyst Rating

Updated: Jan 7, 2025

Strong Buy

Strong Buy
77.78%
Buy
22.22%
Hold
0.00%
Underperform
0.00%
Sell
0.00%

Price Target

No Data

Heat List

Overall